CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
about
A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer.Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer.CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
P2860
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
@ast
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
@en
type
label
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
@ast
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
@en
prefLabel
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
@ast
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
@en
P2093
P2860
P50
P1433
P1476
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
@en
P2093
Ana Alfaro
Ana Laura Sánchez-Sandoval
Ana María Espinosa
Carlos García-Ruiz
E Martha Pérez-Armendariz
Edgar Roman-Bassaure
Eligia Juárez
Ingrid Medina
Mariano Guardado-Estrada
Miriam Bermúdez
P2860
P304
P356
10.1371/JOURNAL.PONE.0137397
P407
P577
2015-09-15T00:00:00Z